VRTX

VERTEX PHARMACEUTICALS INC

VRTX·92532F100·US·Common Stock·Healthcare - Biotechnology-13D/G

VRTX (VERTEX PHARMACEUTICALS INC) is held by 333 institutional investors as of Q2 2026. Largest holders: Capital World Investors ($13B), BlackRock, Inc. ($12B), Capital Research Global Investors ($9.7B). Net institutional sentiment: Mixed. In Q2 2026, 5 members of Congress and 178 funds bought VRTX.

333
Holders
(34 Elite)
$111.4B
Total Value
52% (342)
Consensus
178 buying - 164 selling
13F: Insider & Congress: Updated regularly
VRTX

Smart Money Verdict

View all
Loading verdict
Held by 333 funds
34 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders May 19, 2026 · Activists May 14, 2026 · Congress Aug 5, 2026

InsiderBCBozic CarmenSell $614KMay 15, 2026
ActivistCapital World InvestorsCapital World Investors10.1%May 14, 2026
InsiderBCBozic CarmenSell $3.1MMay 12, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
26.1M(+2.9%)$13B1.5%+76.36%
52
Increased
24.1M(+0.6%)$12B0.2%+35.45%
38
Decreased
19.5M(-7.7%)$9.7B1.4%+24.66%
0
Increased
16.6M(+0.4%)$8.2B0.2%+15.37%
38
Increased
11.9M(+1.2%)$5.9B0.2%+33.87%
39
Increased
8M(+1.9%)$4B0.3%+31.53%
39
Decreased
6.5M(-7.3%)$3.3B0.2%+31.93%
0
Decreased
6M(-2.0%)$3B0.2%+109.23%
0
Decreased
4.9M(-5.2%)$2.4B0.1%+15.40%
0
Decreased
4.7M(-8.4%)$2.3B0.5%+28.54%
0
Decreased
3.9M(-2.1%)$1.9B2.4%+123.93%
0
Increased
3.3M(+507.3%)$1.7B0.4%+16.78%
62
Increased
3.2M(+1.1%)$1.6B0.3%+63.94%
38
Increased
3.2M(+1.7%)$1.6B0.1%+16.88%
32
Increased
3.1M(+1.0%)$1.5B0.3%+92.24%
38
Increased
3M(+5.6%)$1.5B0.1%+30.52%
34
Increased
3M(+9.4%)$1.5B0.9%+43.23%
49
Decreased
3M(-22.8%)$1.3B0.4%+130.47%
0
Decreased
2.6M(-1.1%)$1.3B0.3%+91.75%
0
Decreased
2.5M(-3.0%)$1.2B0.1%+138.81%
0

Showing 1-20 of 346

1 / 18
VRTXVRTXVERTEX PHARMACEUTICALS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used